PTGX logo

Protagonist Therapeutics (PTGX) Long Term Liabilities

Annual Total Long Term Liabilities

$22.03 M
+$22.03 M+100.00%

December 31, 2024


Summary


Performance

PTGX Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPTGXbalance sheetmetrics:

Quarterly Long Term Liabilities

$22.03 M
-$5.33 M-19.49%

December 31, 2024


Summary


Performance

PTGX Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPTGXbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

PTGX Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+100.0%-19.5%
3 y3 years+502.3%-19.5%
5 y5 years-44.3%-19.5%

PTGX Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-100.0%-30.6%-100.0%
5 y5-year-44.3%-100.0%-44.3%-100.0%
alltimeall time-44.3%-100.0%-44.3%-100.0%

Protagonist Therapeutics Long Term Liabilities History

DateAnnualQuarterly
Dec 2024
$22.03 M(>+9900.0%)
$22.03 M(-19.5%)
Sep 2024
-
$27.36 M(-13.8%)
Jun 2024
-
$31.73 M(+9.7%)
Mar 2024
-
$28.92 M(>+9900.0%)
Dec 2023
$0.00(-100.0%)
$0.00(0.0%)
Sep 2023
-
$0.00(0.0%)
Jun 2023
-
$0.00(-100.0%)
Mar 2023
-
$462.00 K(-59.5%)
Dec 2022
$1.14 M(-68.8%)
$1.14 M(-36.8%)
Sep 2022
-
$1.80 M(-26.2%)
Jun 2022
-
$2.45 M(-20.1%)
Mar 2022
-
$3.06 M(-16.3%)
Dec 2021
$3.66 M(-20.8%)
$3.66 M(-16.1%)
Sep 2021
-
$4.36 M(+14.3%)
Jun 2021
-
$3.81 M(-9.7%)
Mar 2021
-
$4.22 M(-8.6%)
Dec 2020
$4.62 M
$4.62 M(-49.6%)
Sep 2020
-
$9.17 M(-58.6%)
Jun 2020
-
$22.14 M(-38.3%)
DateAnnualQuarterly
Mar 2020
-
$35.86 M(-9.3%)
Dec 2019
$39.55 M(+4849.6%)
$39.55 M(+38.8%)
Sep 2019
-
$28.49 M(-6.5%)
Jun 2019
-
$30.47 M(+340.0%)
Mar 2019
-
$6.92 M(+766.6%)
Dec 2018
$799.00 K(+46.1%)
$799.00 K(+0.3%)
Sep 2018
-
$797.00 K(+0.5%)
Jun 2018
-
$793.00 K(+14.3%)
Mar 2018
-
$694.00 K(+26.9%)
Dec 2017
$547.00 K(>+9900.0%)
$547.00 K(+64.8%)
Sep 2017
-
$332.00 K(+300.0%)
Jun 2017
-
$83.00 K(>+9900.0%)
Mar 2017
-
$0.00(0.0%)
Dec 2016
$0.00(-100.0%)
$0.00(0.0%)
Sep 2016
-
$0.00(0.0%)
Jun 2016
-
$0.00(-100.0%)
Mar 2016
-
$1.00 M(-52.7%)
Dec 2015
$2.12 M(+107.5%)
$2.12 M
Dec 2014
$1.02 M
-

FAQ

  • What is Protagonist Therapeutics annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Protagonist Therapeutics?
  • What is Protagonist Therapeutics annual total long term liabilities year-on-year change?
  • What is Protagonist Therapeutics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Protagonist Therapeutics?
  • What is Protagonist Therapeutics quarterly long term liabilities year-on-year change?

What is Protagonist Therapeutics annual total long term liabilities?

The current annual total long term liabilities of PTGX is $22.03 M

What is the all time high annual total long term liabilities for Protagonist Therapeutics?

Protagonist Therapeutics all-time high annual total long term liabilities is $39.55 M

What is Protagonist Therapeutics annual total long term liabilities year-on-year change?

Over the past year, PTGX annual total long term liabilities has changed by +$22.03 M (+100.00%)

What is Protagonist Therapeutics quarterly total long term liabilities?

The current quarterly long term liabilities of PTGX is $22.03 M

What is the all time high quarterly long term liabilities for Protagonist Therapeutics?

Protagonist Therapeutics all-time high quarterly total long term liabilities is $39.55 M

What is Protagonist Therapeutics quarterly long term liabilities year-on-year change?

Over the past year, PTGX quarterly total long term liabilities has changed by -$5.33 M (-19.49%)